<body><div><img src="https://img.particlenews.com/image.php?type=thumbnail_580x000&amp;url=2Mluua_1Gm01cbl00" alt="https://img.particlenews.com/image.php?url=2Mluua_1Gm01cbl00" width="1200" height="600" >SARASOTA, Fla. (WWSB) - As federal policies surrounding medical cannabis continue to evolve, healthcare professionals are taking a closer look at what those changes could mean for patients, medical research and the future of medicine.Professor Sabrina Fayez, director of Lake Erie College of Osteopathic Medicine’s (LECOM) Master of Science in Medical Cannabinoid Therapeutics program, joined ABC7 to discuss the changing medical cannabis landscape and the growing need for specialized education.Fayez said the federal government’s move to reclassify medical cannabis as a Schedule III substance represents an important shift in how its potential medical uses are recognized.However, she emphasized that the change does not immediately affect patients enrolled in Florida’s medical marijuana program.“Currently, there are no immediate changes for medical patients in the state of Florida because even though it’s federally recognized as a Schedule 3 medical substance, the state still manages all state-managed medical dispensaries,” Fayez said.While patients may not notice immediate differences, Fayez said the changing regulatory landscape could create new opportunities for medical research.Cannabis-based treatments have been studied for conditions including epilepsy, cancer-related symptoms and complications associated with chronic illnesses. However, researchers are still working to better understand their effectiveness, potential risks and appropriate uses.“There’s absolutely more research needed,” Fayez said.As interest in cannabinoid-based treatments grows, Fayez believes healthcare professionals need more formal training to help patients make informed decisions.She pointed to Florida’s large population of medical marijuana cardholders as one reason physicians and other healthcare providers should understand both the potential benefits and adverse effects of cannabis-based therapies.“Our future medical professionals need to have knowledge and awareness of medical cannabis and potential adverse effects to translate that to patients in a safe, informed, evidence-based way,” Fayez said.LECOM is working to address that need through its Master of Science in Medical Cannabinoid Therapeutics program.Grounded in osteopathic principles that emphasize whole-person care, the program covers the history of medical cannabis, how cannabinoids interact with the body, dosing strategies, business operations and changing regulations.Fayez said the goal is to equip graduates with the scientific knowledge needed to navigate a rapidly developing area of healthcare.As research continues and regulations evolve, she believes education will play an increasingly important role in helping medical professionals understand where cannabinoid-based treatments may fit into patient care.</div></body>

Block Source: Mysuncoast.com

Misinformation

Clickbait

Old or repetitive news

Explicit content

Location not relevant

SARASOTA, Fla. (WWSB) - As federal policies surrounding medical cannabis continue to evolve, healthcare professionals are taking a closer look at what those changes could mean for patients, medical research and the future of medicine. Professor Sabrina Fayez, director of Lake Erie College of Osteopathic Medicine’s (LECOM) Master of Science...

Medical cannabis changes could expand research, create demand for specialized healthcare training

NewsBreak

SARASOTA, Fla. (WWSB) - As federal policies surrounding medical cannabis continue to evolve, healthcare professionals are taking a closer look at what thos

Medical cannabis changes could expand research, create demand for specialized healthcare training

Comments / 4